Innovega Inc. is developing stylish, lightweight, wearable displays that feature a high-resolution, panoramic-field-of-view system for medical, consumer, and industrial application. The Company is licensing its technology into the $74 billion global vision care market with a focus on image enhancement for the visually impaired. Its transformative patented platform, eMacula™, includes eyewear and iOptik® high-resolution smart contact lenses that work together to deliver broad application in medicine, augmented reality (AR), and virtual reality (VR). The Company has been supported by the Defense Advanced Research Projects Agency (DARPA), National Eye Institute (NEI) of National Institutes of Health (NIH), and National Science Foundation (NSF) and has received investments from strategic partners. The iOptik contact lens is in the FDA De Novo process Phase II clinical trials in progress. The Company is also pursuing FDA 510(k) Clearance for its lens material.

Electronics

Innovega

Steve Willey

Adrianne Kurkciyan

Ilya Volk

Alan Koslow

Bill Meyers

Peter Schuster

Mark Freeman

Jerome A. Legerton

Jay Marsh

The Directors team at Innovega oversees critical strategic functions spanning clinical research, optoelectronics and photonics, finance, and administration. They lead efforts to advance the company's innovative wearable displays and smart contact lenses through clinical trials, regulatory approvals, and strategic partnerships, ensuring Innovega's technology meets the highest standards and reaches its full market potential across medical, consumer, and industrial applications.

Directors

Advisory Team

Leadership Team

��

Directors

About

Team members

Other teams at Innovega

Advisory Team

Leadership Team

��������

Directors

About

Team members

Other teams at Innovega

Advisory Team

Leadership Team

��